______________________________
Deputy Chairman of the DNR Union of Businessmen Aleksandr Polivyanov-Konotop stated that export of pharmaceuticals from Russia to Novorossiya grew almost 200 times in the first half of 2015:
In the first half of 2015, Russia sharply increased its commercial supply of drugs to DNR and LNR, from 3 million Roubles (293,000 Renminbi. 3.015 million INR. 46,000 USD. 61,200 CAD. 65,300 AUD. 41,400 Euros. 30,500 UK Pounds) to 590 million Roubles (57.6 million Renminbi. 592.8 million INR. 9.07 million USD. 12.07 million CAD. 12.87 million AUD. 8.13 million Euros. 6 million UK Pounds). Major Russian pharmaceutical companies reduced their trade with the DNR, but regional producers replaced them. The biggest Russian suppliers reduced their deliveries to the DNR and the LNR for fear of sanctions. In contrast, small suppliers in Rostov Oblast increased their deliveries. In all, they cover more than 75 percent of the market. Because of the Ukrainian blockade, Russia remains the only supplier of drugs.
Maxim Leshchenko, Head of Administration for the DNR Chairman of the Government, pointed up:
Local producers could contribute as well. The Republic has a great potential to produce medicines. A company with operations in Donetsk and Gorlovka could soon take over a significant share of the pharmaceutical products market.
28 September 2015
DAN Donetsk News Agency
Voices from Russia 
You must be logged in to post a comment.